Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ricardo del Olmo
Observed names:
Olmo, Ricardo Del,
R del Olmo,
R. D. Olmo,
R. del Olmo,
Ricardo Del Olmo,
del Olmo, Ricardo
show all 6
Institution:
Instituto de Diagnóstico e Investigaciones Metabólicas
Observed institutions:
Karolinska University Hospital,
University of Ferrara,
Royal London Hospital,
Karolinska Institutet,
Instituto de Diagnóstico e Investigaciones Metabólicas,
Hospital Universitario de Fuenlabrada
show all 6
ORCID:
0000-0002-8375-1939
Observed ORCID:
0000-0002-8375-1939
OpenAlex ID:
A5006800847
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
2014
·
Andrea Rossi
, Thys van der Molen
, et al.
·
European Respiratory Journal
·
126
PDF
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
2022
·
Rod Hughes
, Eleni Rapsomaniki
, et al.
·
Respiratory Medicine
·
50
PDF
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
2023
·
Richard Beasley
, Rod Hughes
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
45
Prevalencia de enfermedad pulmonar obstructiva crónica en 6 aglomerados urbanos de Argentina: el estudio EPOC.AR
2017
·
Andrés L. Echazarreta
, Sergio J. Arias
, et al.
·
Archivos de Bronconeumología
·
45
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
2023
·
Alvar Agustí
, Rod Hughes
, et al.
·
ERJ Open Research
·
33
PDF
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
2025
·
David J Jackson
, Njira L Lugogo
, et al.
·
The Lancet Respiratory Medicine
·
27
PDF
Prevalence of COPD in 6 Urban Clusters in Argentina: The EPOC.AR Study
2018
·
Andrés L. Echazarreta
, Sergio J. Arias
, et al.
·
Archivos de Bronconeumología
·
25
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
2022
·
Sarowar Muhammad Golam
, Christer Janson
, et al.
·
Respiratory Medicine
·
23
PDF
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
2023
·
Bo Ding
, Stephanie Chen
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
16
PDF
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
2024
·
Alberto Papi
, Rod Hughes
, et al.
·
Therapeutic Advances in Respiratory Disease
·
15
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
2023
·
Rod Hughes
, Eleni Rapsomaniki
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
11
PDF
Breaking the vicious circle—the Asthma Referral Identifier (ReferID) tool
2022
·
Maarten Beekman
, Julie Hales
, et al.
·
npj Primary Care Respiratory Medicine
·
11
PDF
Tezepelumab Reduces and Eliminates OCS Use in OCS-Dependent Patients With Severe Asthma: Primary Results from the Phase 3b WAYFINDER Study
2025
·
D.J. Jackson
, N. Lugogo
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
9
ESICM LIVES 2016: part two
2016
·
S. Sivakumar
, for the PRoVENT investigators and the PROVE Network
, et al.
·
Intensive Care Medicine Experimental
·
7
PDF
Long-term outcomes in patients with Pre-COPD or PRISm in NOVELTY
2023
·
Eleni Rapsomaniki
, Rod Hughes
, et al.
·
European Respiratory Journal
·
4
Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease
2025
·
Richard Beasley
, Rod Hughes
, et al.
·
Annals of the American Thoracic Society
·
2
Persistence of SARS-CoV-2 RNA shedding and infectivity in immunized population: Prospective study along different epidemiological periods in Argentina
2023
·
Clara Theaux
, Yamila Martin
, et al.
·
PLoS ONE
·
2
PDF
El asma no controlada en la atención primaria: implementación y uso práctico de ReferID
2023
·
Gabriela Chirino
, Ricardo del Olmo
, et al.
·
Respirar
·
1
PDF
INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results
2015
·
Andrea Rossi
, Thys Van der Molen
, et al.
·
European Respiratory Journal
·
1
Salmeterol/fluticasone combination instead of indacaterol orvice-versa?
2015
·
Andrea Rossi
, Thys van der Molen
, et al.
·
European Respiratory Journal
·
1
PDF
Asthma admissions: Characteristics of patients admitted to a specialized respiratory hospital
2013
·
Fabían Caro
, Santiago Auteri
, et al.
·
European Respiratory Journal
·
1
P79 Effect of tezepelumab on lung function in oral corticosteroid-dependent patients with severe asthma and comorbid CRSwNP or CRSsNP in the phase 3b WAYFINDER study
2026
·
DJ Jackson
, P Chanez
, et al.
·
Thorax
PDF
Colombian consensus on cardiopulmonary risk in patients with chronic obstructive pulmonary disease (COPD) from the Colombian Association of Pulmonology and Thoracic Surgery and the Colombian Society of Cardiology and Cardiovascular Surgery
2026
·
Olga M. García-Morales
, Alejandro Casas-Herrera
, et al.
·
Revista Colombiana de Cardiología (English Edition)
PDF
Consenso colombiano de riesgo cardiopulmonar en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) de la Asociación Colombiana de Neumología y Cirugía de Tórax y la Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
2026
·
Olga M. García-Morales
, Alejandro Casas-Herrera
, et al.
·
Revista Colombiana de Cardiología
PDF
Effect of tezepelumab on lung function in oral corticosteroid-dependent patients with severe asthma and comorbid CRSwNP or CRSsNP in the phase 3b WAYFINDER study
2026
·
Pascal Chanez
, David J. Jackson
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
47
Citation count:
482
H-index:
11
I10-index:
14
Year
Topic
Type
